Adam J. Schoenfeld, MD
Thoracic Medical Oncologist, Cellular Therapist & Early Drug Development Specialist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
About Me
- Assistant Attending Physician
I am a medical oncologist devoted to caring for people with lung cancer and bringing novel immunotherapies to patients with solid tumors. Immunotherapy is a type of cancer treatment that uses a person’s own immune system to attack cancer cells in much the same way that it would bacteria or viruses. This approach has shown promise in lung cancer and other solid tumors.
I work closely with a multidisciplinary team including radiation oncologists, thoracic surgeons, pulmonologists, and pathologists, among other experts, to create a personalized treatment plan tailored to each patient’s wants and needs. We know that receiving a diagnosis of cancer is daunting. My team and I are committed to supporting each patient and their family through their experience with cancer. We work together to provide every person who comes to us with the highest level of care. From our initial visit onward, we are here for our patients and will spend as much time as needed to ensure that everyone understands and agrees with the care plan.
Read more
Sometimes, the best treatment is available through a clinical trial. We lead many clinical trials for people with lung cancer at Memorial Sloan Kettering Cancer Center (MSK), which are open to patients who are interested and eligible. If a patient would like to participate in a clinical trial, my colleagues and I take the time to answer any and all questions about the process. Painting a clear picture of what the experience will be like is important to us, because it helps our patients make informed decisions about their care.
My research focuses on using innovative strategies to harness the immune system to treat cancer. I am a member of MSK’s Cellular Therapeutics Center and Early Drug Development Service, where I design and lead early-phase clinical trials that use genetically engineered versions of a patient’s immune cells as living drugs to fight their cancer. I work closely with the scientists who pioneered these techniques to bring cutting-edge approaches to difficult-to-treat tumors.
A thoracic medical oncologist is a cancer doctor who specializes in thoracic (thor-A-sik) cancers. These are cancers that have to do with the chest, including lung, tracheal (windpipe), and thymic (thymus) cancers.
A cellular therapy specialist is a doctor with special training in using cell therapies to treat health conditions such as cancer. Therapies can include chimeric antigen receptor (CAR) T cell therapy.
An early drug development specialist tests new drugs to treat cancer. They have special training in research studies, known as clinical trials.
My Specialties
- Lung Cancer
- Immunotherapy
- Adoptive Cellular Therapy
- Clinical Trials
Education
- MD, University of California, San Francisco
Residencies
- Internal Medicine - University of California, San Francisco
Awards and Honors
- Conquer Cancer Career Development Award, Conquer Cancer Foundation of the American Society of Clinical Oncology (2022)
- Young Investigator Award, American Society of Clinical Oncology & Conquer Cancer Foundation (2019)
- Conquer Cancer Foundation Merit Award, American Society of Clinical Oncology Annual Meeting (2019, 2020)
Fellowships
- Medical Oncology - Memorial Sloan Kettering Cancer Center
Board Certifications
- Internal Medicine
- Medical Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Dr. Schoenfeld sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
See all Cellular Therapy Service doctors
Clinical Trials
- Clinical Trials Investigated by Dr. Schoenfeld
- A Phase 1 Study of AB248 Alone or With Pembrolizumab Immunotherapy in People With Solid Tumors
- A Phase 1 Study of AFNT-211 Cell Therapy in People With Solid Tumors
- A Phase 1 Study of LY4050784 in People With Advanced Solid Tumors
- A Phase I Study of STK-012 Alone and with Pembrolizumab Immunotherapy in People with Solid Tumors
Read more
- A Phase II Study of LN-145 Immunotherapy in People with Metastatic Non-Small-Cell Lung Cancer
- Clinical Trials Co-Investigated by Dr. Schoenfeld
- A Phase 1 Study of PRT3789 in People With Solid Tumors
- A Phase 1/2 Study of OBX-115 Cell Therapy and Acetazolamide in People With Advanced Melanoma or Lung Cancer
- A Phase I Study of ADP-A2M4CD8 with or without Nivolumab Immunotherapy in People with Urothelial Cancer, Non-Small Cell Lung Cancer, or Endometrial Cancer
- A Phase I Study of AGEN1811 and Balstilimab Immunotherapy in People with Fibrolamellar Carcinoma or Another Type of Gastrointestinal Cancer
- A Phase I/II Study of IOV-4001 in People with Inoperable or Metastatic Melanoma or Non-Small Cell Lung Cancer
- A Phase II Study of Targeted Radiation Therapy for People with Non-Small Cell Lung Cancer that Spread to the Liver
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Schoenfeld’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Adam J. Schoenfeld discloses the following relationships and financial interests:
-
Amgen
Professional Services and Activities -
Bristol-Myers Squibb
Professional Services and Activities -
Enara Bio Limited
Professional Services and Activities -
Heat Biologics, Inc.
Professional Services and Activities -
Immunocore
Professional Services and Activities -
Iovance Biotherapeutics, Inc.
Professional Services and Activities -
Johnson & Johnson
Professional Services and Activities
-
KSQ Therapeutics
Professional Services and Activities -
Legend Biotech USA Inc.
Professional Services and Activities -
Lyell Immunopharma, Inc.
Professional Services and Activities -
Merck & Co Inc.
Professional Services and Activities -
Perceptive Advisors, LLC
Professional Services and Activities -
Prelude Therapeutics
Professional Services and Activities -
Umoja Biopharma, Inc.
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].